Dominari (NASDAQ:DOMH) Issues Quarterly Earnings Results

Dominari (NASDAQ:DOMH) posted its earnings results on Tuesday. The company reported $0.20 EPS for the quarter, Zacks reports. Dominari had a negative return on equity of 32.89% and a negative net margin of 180.22%.

Dominari Trading Down 0.3 %

DOMH stock traded down $0.01 during mid-day trading on Tuesday, reaching $3.90. 159,846 shares of the stock traded hands, compared to its average volume of 1,625,910. The stock’s fifty day moving average is $6.02 and its 200-day moving average is $3.18. The company has a market cap of $42.56 million, a P/E ratio of -1.01 and a beta of 0.86. Dominari has a 52-week low of $0.83 and a 52-week high of $13.58.

Dominari Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, March 3rd. Stockholders of record on Monday, February 24th were issued a dividend of $0.32 per share. The ex-dividend date was Monday, February 24th.

About Dominari

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.